Supporter News

ICBCC 2023 Patient Impact Statement

In 2021, Lymphoma Coalition joined the International COVID-19 Blood Cancer Coalition (ICBCC). The ICBCC comprises representatives from the global patient advocacy and clinical community to address the specific impact of COVID-19 on immunocompromised blood cancer patients (both acute and chronic), like those living with Chronic Lymphocytic Leukaemia (CLL) and other Non Hodgkin lymphomas (NHLs). In…

Lymphoma Coalition at EBMT 2023

Lymphoma Coalition is delighted to announce its participation in the 49th Annual European Society for Blood and Marrow Transplantation (EBMT) meeting, taking place this weekend in Paris France. Presenting the poster, “P877: A Cross-Sectional Study Examining Potential Demographic Barriers to Receiving Information on Clinical Trials in Relapsed/Refractory Patients Who Have Received Stem Cell Transplants (SCT).…

Ukraine Conflict Response Update

Shortly after the armed conflict started on 24 February 2022, LC reached out to both its member organisations in Ukraine and Russia to see how this was impacting their activities and if LC could help. While we all have our political beliefs surrounding this conflict, LC’s first thought was how is this impacting patients? Our…

Lymphoma Coalition at #ASH22

Lymphoma Coalition is pleased to attend the American Society of Hematology (ASH) symposium in New Orleans this weekend, presenting Poster Abstract #3537: “Patient Reported Experience with Fatigue, a Cross-Sectional Study Examining Indolent and Aggressive Lymphomas.” Poster ASH Fatigue 3537 Download The presentation will take place Sunday, Dec 11th: from 6:00 PM-8:00. Session 902. Health Services…

An MPN Update with Drs Ruben Mesa and Robyn Scherber

Dr. Ruben Mesa and Dr. Robyn Scherber hematologists from the Mays Cancer Center, home to UT Health San Antonio MD Anderson discuss the latest updates regarding new treatments for myeloproliferative neoplasms (MPNS) including essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF). They also discuss the latest updates from the 2019 American Society of Hematology…